Page 44 - Robert Kramer News Today : Breaking News, Live Updates & Top Stories | Vimarsana

In wake of Emergent's vaccine problems, CEO's stock trades come under scrutiny Johnson & Johnson manufacturer’s embattled history with the FDA Replay Video UP NEXT For Emergent BioSolutions, Feb. 8 was a day to revel in their success -- at least as far as the public was concerned. Standing alongside Maryland Gov. Larry Hogan at their Baltimore-area plant, Emergent CEO Robert Kramer boasted about the biotech firm's role as "one of the key suppliers" helping to produce two promising COVID-19 vaccines, and its "valuable contribution to society in being able to make hundreds of millions of ...

SAUL LOEB/AFP via Getty Images (NEW YORK) -- For Emergent BioSolutions, Feb. 8 was a day to revel in their success -- at least as far as the public was concerned. Standing alongside Maryland Gov. Larry Hogan at their Baltimore-area plant, Emergent CEO Robert Kramer boasted about the biotech firm's role as "one of the key suppliers" helping to produce two promising COVID-19 vaccines, and its "valuable contribution to society in being able to make hundreds of millions of doses available." Kramer's comments that ...

New details show a woman arrested on Friday as the suspected driver in a fatal wrong way crash that happened Feb. 10, may have been inebriated and had a previous DUI charge, according to Maricopa County Superior Court records. Court records show that Hannah Dike, who was arrested by the Arizona Department of Public Safety, tested with a blood alcohol level of 0.275% after the incident. They also state that Dike had been charged with a misdemeanor DUI in January 2019.  At 12:31 a.m. on Feb. 10, a wrong way driver going east on the westbound lane of Interstate 10 near Ray Road in Chandl...

A new report from The Washington Post found that CEO Robert Kramer sold the stocks in January and early February, right before the price fell by more than 50% on February 19 after a financial report.

Apr 26, 2021 11:30am The head of Emergent BioSolutions sold more than $10 million in company shares earlier this year before prices began to slide. Emergent BioSolutions has faced a number of back-to-back PR crises since production issues at its Baltimore facility placed the company under intense scrutiny. The CDMO's stock price has tumbled as a result, but it appears CEO Robert Kramer cashed out some of his shares just in time.  Citing SEC filings, Kramer sold more than $10 million worth of Emergent stock in January and early February, right before the company’s shares began to tumble�...